US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BRIACELL THERAPEUTICS CORP C/WTS (TO PUR COM) 15/01/2031

0.8701

-0.0499-5.42%

Volume:7K

Turnover:6.14K

Market Cap:- -

PE:- -

High:0.9500

Open:0.9500

Low:0.8700

Close:0.9200

52wk High:1.40

52wk Low:0.6100

Shares:- -

Float Shares:- -

Volume Ratio:0.64

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Briacell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-Mel+™

THOMSON REUTERS

Briacell Receives FDA Clearance to Initiate Bria-Pros+™ Clinical Study in Prostate Cancer

THOMSON REUTERS

Briacell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer

THOMSON REUTERS

Briacell Therapeutics Corp - Arrangement Provides Manufacturing Capacity for Phase 3 Study and Commercial Scalability

THOMSON REUTERS

Briacell Therapeutics Corp - Announces Manufacturing Arrangement with Fujifilm Biotechnologies California for Bria-imt

THOMSON REUTERS

Briacell Therapeutics Announces Closing of Offering

THOMSON REUTERS

BRIEF-Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share

Briacell Therapeutics Announces Pricing of Offering

THOMSON REUTERS

Briacell Therapeutics Corp - Interim Topline Data From Phase 3 Bria-Abc Study Expected in 2026

THOMSON REUTERS

Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients

THOMSON REUTERS

Briacell Therapeutics Corp - to Initiate Phase 1/2a Study of Bria-Bres+ in Coming Months

THOMSON REUTERS

Briacell Receives FDA Clearance to Initiate Bria-Bres+™ Clinical Study in Breast Cancer

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BCTXL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCTXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTXL\",,,,,undefined,":{"symbol":"BCTXL","market":"US","secType":"STK","nameCN":"BRIACELL THERAPEUTICS CORP C/WTS (TO PUR COM) 15/01/2031","latestPrice":0.8701,"timestamp":1789065735326,"preClose":0.92,"halted":0,"volume":6878,"delay":0,"changeRate":-0.054239130434782665,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-0.0499,"latestTime":"09-10 15:23:46 EDT","open":0.95,"high":0.95,"low":0.87,"amount":6144.3268351,"amplitude":0.086957,"askPrice":0.97,"askSize":100,"bidPrice":0.83,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.92,"volumeRatio":0.637844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTXL\",,,,,undefined,":{"symbol":"BCTXL","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.637844,"shares":0,"dividePrice":0,"high":0.95,"amplitude":0.086957,"preClose":0.92,"low":0.87,"week52Low":0.61,"pbRate":"--","week52High":1.4,"institutionHeld":0,"latestPrice":0.8701,"committee":0.960784,"eps":0,"divideRate":0,"volume":6878,"delay":0,"ttmEps":0,"open":0.95,"prevYearClose":0.65,"prevWeekClose":0.9466,"prevMonthClose":0.925,"prevQuarterClose":0.89,"fiveDayClose":0.94,"twentyDayClose":0.85,"sixtyDayClose":0.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCTXL\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCTXL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCTXL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCTXL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661275391","title":"Briacell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-Mel+™","url":"https://stock-news.laohu8.com/highlight/detail?id=2661275391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661275391?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:30","pubTimestamp":1787571000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA3GS0GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657935549","title":"Briacell Receives FDA Clearance to Initiate Bria-Pros+™ Clinical Study in Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2657935549","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657935549?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:30","pubTimestamp":1785929400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUAQRGKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651493134","title":"Briacell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651493134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651493134?lang=en_us&edition=fundamental","pubTime":"2026-07-16 19:30","pubTimestamp":1784201400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA1Z8CYQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651570574","title":"Briacell Therapeutics Corp - Arrangement Provides Manufacturing Capacity for Phase 3 Study and Commercial Scalability","url":"https://stock-news.laohu8.com/highlight/detail?id=2651570574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651570574?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:30","pubTimestamp":1784115032,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H05G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXL","BCTXZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651457050","title":"Briacell Therapeutics Corp - Announces Manufacturing Arrangement with Fujifilm Biotechnologies California for Bria-imt","url":"https://stock-news.laohu8.com/highlight/detail?id=2651457050","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651457050?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:30","pubTimestamp":1784115032,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H05G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640923419","title":"Briacell Therapeutics Announces Closing of Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640923419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640923419?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:05","pubTimestamp":1780430701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUAZJDBX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640897909","title":"BRIEF-Briacell Therapeutics Prices 1.45 Million Common Shares  At $3.25 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2640897909","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640897909?lang=en_us&edition=fundamental","pubTime":"2026-06-01 08:01","pubTimestamp":1780272090,"startTime":"0","endTime":"0","summary":"BRIEF-Briacell Therapeutics Prices 1.45 Million Common Shares  At $3.25 Per ShareMay 31 (Reuters) - Briacell Therapeutics Corp BCT.TO:BRIACELL THERAPEUTICS ANNOUNCES PRICING OF OFFERINGBRIACELL THERAP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nTUA6YWLQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTXL","BCTXZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640989248","title":"Briacell Therapeutics Announces Pricing of Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2640989248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640989248?lang=en_us&edition=fundamental","pubTime":"2026-06-01 07:59","pubTimestamp":1780271976,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nTUA6YWLQL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXL","BCTXZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634521557","title":"Briacell Therapeutics Corp - Interim Topline Data From Phase 3 Bria-Abc Study Expected in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634521557","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634521557?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA25STXX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634215630","title":"Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2634215630","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634215630?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:30","pubTimestamp":1778585400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA25STXX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633872801","title":"Briacell Therapeutics Corp - to Initiate Phase 1/2a Study of Bria-Bres+ in Coming Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2633872801","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633872801?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA9RCHWB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXZ","BCTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187194","title":"Briacell Receives FDA Clearance to Initiate Bria-Bres+™ Clinical Study in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187194","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187194?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUA9RCHWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BCTXL","BCTXZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}